139 related articles for article (PubMed ID: 11736696)
21. Short-term ACE inhibition confers long-term protection against target organ damage.
Hale TM; Robertson SJ; Burns KD; deBlois D
Hypertens Res; 2012 Jun; 35(6):604-10. PubMed ID: 22318205
[TBL] [Abstract][Full Text] [Related]
22. Growth hormone aggravates renal abnormalities induced by neonatal enalapril treatment.
Nilsson AB; Friberg P; Bönquist L; Lasaitiene D; Marcussen N; Chen Y
Pediatr Nephrol; 2003 Sep; 18(9):878-86. PubMed ID: 12883983
[TBL] [Abstract][Full Text] [Related]
23. Tumor necrosis factor-alpha gene expression in diabetic nephropathy: relationship with urinary albumin excretion and effect of angiotensin-converting enzyme inhibition.
Navarro JF; Milena FJ; Mora C; León C; Claverie F; Flores C; García J
Kidney Int Suppl; 2005 Dec; (99):S98-102. PubMed ID: 16336586
[TBL] [Abstract][Full Text] [Related]
24. Urinary acidification and net acid excretion in adult rats treated neonatally with enalapril.
Guron G; Marcussen N; Friberg P
Am J Physiol; 1998 Jun; 274(6):R1718-24. PubMed ID: 9841484
[TBL] [Abstract][Full Text] [Related]
25. Comparison of enalapril and valsartan in cyclosporine A-induced hypertension and nephrotoxicity in spontaneously hypertensive rats on high-sodium diet.
Lassila M; Finckenberg P; Pere AK; Krogerus L; Ahonen J; Vapaatalo H; Nurminen ML
Br J Pharmacol; 2000 Jul; 130(6):1339-47. PubMed ID: 10903974
[TBL] [Abstract][Full Text] [Related]
26. Renin-angiotensin system blockade prevents the increase in plasma transforming growth factor beta 1, and reduces proteinuria and kidney hypertrophy in the streptozotocin-diabetic rat.
Erman A; Veksler S; Gafter U; Boner G; Wittenberg C; van Dijk DJ
J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):146-51. PubMed ID: 15526251
[TBL] [Abstract][Full Text] [Related]
27. Effect of enalapril and losartan on the events that precede diabetic nephropathy in rats.
Volpini RA; da Silva CG; Costa RS; Coimbra TM
Diabetes Metab Res Rev; 2003; 19(1):43-51. PubMed ID: 12592643
[TBL] [Abstract][Full Text] [Related]
28. IGF-I treatment attenuates renal abnormalities induced by neonatal ACE inhibition.
Nilsson AB; Nitescu N; Chen Y; Guron GS; Marcussen N; Matejka GL; Friberg P
Am J Physiol Regul Integr Comp Physiol; 2000 Sep; 279(3):R1050-60. PubMed ID: 10956265
[TBL] [Abstract][Full Text] [Related]
29. Tubular mitochondrial alterations in neonatal rats subjected to RAS inhibition.
Lasaitiene D; Chen Y; Mildaziene V; Nauciene Z; Sundelin B; Johansson BR; Yano M; Friberg P
Am J Physiol Renal Physiol; 2006 May; 290(5):F1260-9. PubMed ID: 16249276
[TBL] [Abstract][Full Text] [Related]
30. Renal cortex remodeling in nitric oxide deficient rats treated with enalapril.
Barbuto N; Almeida JR; Pereira LM; Mandarim-de-Lacerda CA
J Cell Mol Med; 2004; 8(1):102-8. PubMed ID: 15090265
[TBL] [Abstract][Full Text] [Related]
31. Reducing blood pressure in SHR with enalapril provokes redistribution of NHE3, NaPi2, and NCC and decreases NaPi2 and ACE abundance.
Yang LE; Leong PK; McDonough AA
Am J Physiol Renal Physiol; 2007 Oct; 293(4):F1197-208. PubMed ID: 17652375
[TBL] [Abstract][Full Text] [Related]
32. Postnatal time frame for renal vulnerability to enalapril in rats.
Guron G; Marcussen N; Nilsson A; Sundelin B; Friberg P
J Am Soc Nephrol; 1999 Jul; 10(7):1550-60. PubMed ID: 10405211
[TBL] [Abstract][Full Text] [Related]
33. A role for the extracellular matrix component hyaluronan in kidney dysfunction during ACE-inhibitor fetopathy.
Hansell P; Palm F
Acta Physiol (Oxf); 2015 Apr; 213(4):795-804. PubMed ID: 25600777
[TBL] [Abstract][Full Text] [Related]
34. Effects of an angiotensin-converting enzyme inhibitor on the inflammatory response in in vivo and in vitro models.
Hagiwara S; Iwasaka H; Matumoto S; Hidaka S; Noguchi T
Crit Care Med; 2009 Feb; 37(2):626-33. PubMed ID: 19114890
[TBL] [Abstract][Full Text] [Related]
35. Benazepril, an angiotensin-converting enzyme inhibitor, alleviates renal injury in spontaneously hypertensive rats by inhibiting advanced glycation end-product-mediated pathways.
Liu XP; Pang YJ; Zhu WW; Zhao TT; Zheng M; Wang YB; Sun ZJ; Sun SJ
Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):287-96. PubMed ID: 19018797
[TBL] [Abstract][Full Text] [Related]
36. Radiation nephropathy in rats and its modification by the angiotensin converting enzyme inhibitor enalapril.
Yildiz F; Atahan II; Yildiz O
Radiat Med; 2000; 18(3):153-9. PubMed ID: 10972545
[TBL] [Abstract][Full Text] [Related]
37. ACE inhibition increases expression of the ETB receptor in kidneys of mice with unilateral obstruction.
Moridaira K; Morrissey J; Fitzgerald M; Guo G; McCracken R; Tolley T; Klahr S
Am J Physiol Renal Physiol; 2003 Jan; 284(1):F209-17. PubMed ID: 12473537
[TBL] [Abstract][Full Text] [Related]
38. Hormonal regulation of renomedullary hyaluronan.
Rügheimer L; Johnsson C; Maric C; Hansell P
Acta Physiol (Oxf); 2008 Jun; 193(2):191-8. PubMed ID: 18081884
[TBL] [Abstract][Full Text] [Related]
39. Protection against L-NAME-induced reduction in cardiac output persists even after cessation of angiotensin-converting enzyme inhibitor treatment.
Biwer LA; Broderick TL; Xu H; Carroll C; Hale TM
Acta Physiol (Oxf); 2013 Jan; 207(1):156-65. PubMed ID: 22834875
[TBL] [Abstract][Full Text] [Related]
40. Hepatic morphological alterations, glycogen content and cytochrome P450 activities in rats treated chronically with N(omega)-nitro-L-arginine methyl ester (L-NAME).
Tarsitano CA; Paffaro VA; Pauli JR; da Silva GH; Saad MJ; Salgado I; da Cruz-Höfling MA; Hyslop S
Cell Tissue Res; 2007 Jul; 329(1):45-58. PubMed ID: 17436021
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
